1 Clinical Research Fellow, Department of Medical Oncology, The Royal Marsden Hospital, London, UK 2 Specialist Registrar, Department of Medical Oncology, The Royal Marsden Hospital, London, UK 3 Clinical Research Fellow, Department of Medical Oncology, Guy’s and St. Thomas’ Hospital, London, UK 4 Consultant Medical Oncologist, Department of Medical Oncology, Guy’s and St. Thomas’ Hospital, Lon...

S. Oudard1, A. Angelergues1, I. Gonzalez Maeso2, N. Delanoy1, A. Flechon3, M. Özgüroğlu4, D.E. Castellano5, A. Guillot6, S. Le Moulec7, E. Esteban8, J. Munarriz9, B. Campos10, J. Bellmunt11 Medical Oncology Service, Georges Pompidou Hospital and Rene Descartes University, Paris, FRANCE Medical Oncology Department, University Hospital del Mar-IMIM, Barcelona, SPAIN Oncology Departement, Centre L...

1Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas; 2Department of Radiation Oncology, University of Michigan Health System, Ann Arbor, Michigan; 3Department of Radiation Oncology, University of Virginia Health System, Charlottesville, Virginia; 4Department of Radiation Oncology, University of Colorado, Denver, Aurora, Colorado; 5Department of Radi...

1Department of Clinical Oncology, Queen Mary Hospital, Pokfulam, Hong Kong 2Department of Gynecologic Oncology, University Hospital Erlangen, 91023 Erlangen, Germany 3Department of Clinical Oncology, Chinese University of Hong Kong, Shatin, Hong Kong 4Department of Medical Oncology, Chiang Mai University, Chiang Mai 50200, Thailand 5Head and Neck Oncology, Dana-Farber Cancer Institute, Harvard ...

From the Division of Medical Oncology at S. Maria Goretti Hospital, Latina, Italy (GF), the Division of Medical Oncology at Treviglio Hospital, Treviglio, Italy (MM, SB), the Department of Medical Oncology at University “La Sapienza,” Rome, Italy (SD), Fondazione S. Maugeri, Pavia, Italy (CM), and the Division of Medical Oncology at the European Institute of Oncology, Milano, Italy (GC). E-mail...

EDITORIAL article Front. Oncol., 14 July 2023Sec. Neuro-Oncology and Neurosurgical Oncology Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1220063

Adverse effects and hazards which have their origin from radiation using conventional techniques like 3-D conformal radiotherapy and total radiation doses are well known. However little is known about the sprectum of especially late toxicity after radiation using new technologies like intensity modulated radiotherapy (IMRT) combined with novel target volume and dose concepts. Since IMRT allows ...

46 RETINA TODAY SEPTEMBER 2015 M etastatic tumors in the eye are most commonly found in the choroid.1 In an analysis of 950 metastatic foci in 520 eyes, the tumors were located in the choroid in 88% of cases.1 This is believed to be due to the abundant vascular supply to the choroid from the posterior ciliary arteries.2 In this analysis, the most common sites of primary cancer to metastasize to...

1Division of Hematology and Oncology, Sainte-Justine Hospital, University of Montreal, Montreal, QC, Canada; 2Departments of Pediatric Oncology, Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA; 3Division of Pediatric Hematology/Oncology, University of Rochester Medical Center, Rochester, NY; 4Division of Pediatric Hematology/Oncology, McMaster University, Hamil...